PROVO, Utah, Feb. 9 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that its board of directorsdeclared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior
"Because of our financial stability and strong cash flow, we are increasing our dividend for the eighth consecutive year," said Truman Hunt, president and chief executive officer. "Continually increasing our dividend, particularly during challenging economic times, demonstrates our commitment to increasing shareholder value and is an effective use of our cash."
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its patent-pending ageLOC™ anti-aging platform and flagship products including the Galvanic Spa® System II, Tru Face® Essence Ultra and LifePak® nano. A global direct selling company, Nu Skin operates in 48 markets worldwide and has more than 760,000 independent sales representatives. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.
Please note: This filing contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, including the company's current expectations regarding the amount and timing of future dividend payments. These forward-looking statements reflect the company's current estimates and expectations and are subject to various risks and uncertainties that could cause actual results to differ materially from any forward-looking statement in this filing. These risks and uncertainties include the risk that any negative changes in the company's net earnings, financial condition, cash requirements, future prospects or other factors deemed relevant by the company's board of directors could cause the company to reduce or discontinue the payment of quarterly dividends. The forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K filed on February 27, 2009 and Quarterly Reports on Form 10-Q filed on May 8, 2009, August 7, 2009 and November 9, 2009. The forward-looking statements set forth the company's beliefs as of the date of this release, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
SOURCE Nu Skin Enterprises, Inc.
Subscribe to our Free Newsletters!
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...View All